Loading…
UTI - Pharma & Healthcare Fund
Disclosed for 41 months, Jan 2014 to Jun 2017. This scheme is no longer reporting.
Portfolio value
₹331 Cr
up ₹16.4 Cr vs Sep 2015
- Stocks held
- 24
- down 1 vs Sep 2015
- Top 10 weight
- 75.6%
- of the portfolio in its ten largest
- Cash & debt
- 9.4%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 5
UTI - Pharma & Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In October 2015 it disclosed 24 stocks worth ₹331 Cr, up ₹16.4 Cr from Sep 2015. Its largest positions were Sun Pharmaceutical Industries Limited (21.4%), Dr. Reddy's Laboratories Limited (12.5%), Lupin Limited (11.8%); the ten largest together made up 75.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 89.6% of its equity. Cash and debt stood at 9.4%. Compared with Sep 2015 the fund entered 0 new stocks and exited 1.
Against 227 other Sectoral / Thematic funds
Concentration
97%
Top-10 weight is higher than 97% of peers
Breadth
5%
Holds more stocks than 5% of peers
Cash
93%
Holds more cash than 93% of peers
Holdings in October 2015
Download CSVEvery line the fund disclosed, with the change against Sep 2015. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 21.37%
- Δ weight
- up 3.17 pts
- Value
- ₹70.7 Cr
- Δ value
- up ₹13.5 Cr
- Status
- Added
- Weight
- 12.46%
- Δ weight
- down 0.29 pts
- Value
- ₹41.3 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 11.83%
- Δ weight
- down 1.47 pts
- Value
- ₹39.2 Cr
- Δ value
- down ₹2.7 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 9.40%
- Δ weight
- down 1.16 pts
- Value
- ₹31.1 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 9.24%
- Δ weight
- up 0.98 pts
- Value
- ₹30.6 Cr
- Δ value
- up ₹4.6 Cr
- Status
- Added
- Weight
- 4.60%
- Δ weight
- up 0.15 pts
- Value
- ₹15.2 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 4.52%
- Δ weight
- down 0.07 pts
- Value
- ₹15 Cr
- Δ value
- up ₹50 L
- Status
- Added
- Weight
- 3.44%
- Δ weight
- up 0.49 pts
- Value
- ₹11.4 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
- Weight
- 2.97%
- Δ weight
- down 0.44 pts
- Value
- ₹9.8 Cr
- Δ value
- down ₹89 L
- Status
- Trimmed
- Weight
- 2.72%
- Δ weight
- up 0.38 pts
- Value
- ₹9 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 2.46%
- Δ weight
- up 0.97 pts
- Value
- ₹8.2 Cr
- Δ value
- up ₹3.4 Cr
- Status
- Added
- Weight
- 2.23%
- Δ weight
- down <0.01 pts
- Value
- ₹7.4 Cr
- Δ value
- up ₹35 L
- Status
- Added
- Weight
- 1.59%
- Δ weight
- down 0.04 pts
- Value
- ₹5.3 Cr
- Δ value
- up ₹12 L
- Status
- Added
- Weight
- 1.51%
- Δ weight
- up 0.09 pts
- Value
- ₹5 Cr
- Δ value
- up ₹54 L
- Status
- Added
- Weight
- 1.48%
- Δ weight
- down 0.23 pts
- Value
- ₹4.9 Cr
- Δ value
- down ₹47 L
- Status
- Trimmed
- Weight
- 1.28%
- Δ weight
- down 0.09 pts
- Value
- ₹4.2 Cr
- Δ value
- down ₹6 L
- Status
- Trimmed
- Weight
- 1.13%
- Δ weight
- up 0.22 pts
- Value
- ₹3.7 Cr
- Δ value
- up ₹88 L
- Status
- Added
- Weight
- 1.09%
- Δ weight
- up 0.26 pts
- Value
- ₹3.6 Cr
- Δ value
- up ₹100 L
- Status
- Added
- Weight
- 1.09%
- Δ weight
- up 1.01 pts
- Value
- ₹3.6 Cr
- Δ value
- up ₹3.3 Cr
- Status
- Added
- Weight
- 0.94%
- Δ weight
- down 0.01 pts
- Value
- ₹3.1 Cr
- Δ value
- up ₹11 L
- Status
- Added
- Weight
- 0.66%
- Δ weight
- down 0.08 pts
- Value
- ₹2.2 Cr
- Δ value
- down ₹15 L
- Status
- Trimmed
- Weight
- 0.66%
- Δ weight
- down 0.02 pts
- Value
- ₹2.2 Cr
- Δ value
- up ₹6 L
- Status
- Added
- Weight
- 0.65%
- Δ weight
- up 0.01 pts
- Value
- ₹2.2 Cr
- Δ value
- up ₹14 L
- Status
- Added
- Weight
- 0.44%
- Δ weight
- down 0.02 pts
- Value
- ₹1.4 Cr
- Δ value
- up ₹2 L
- Status
- Added
- Weight
- 0.21%
- Δ weight
- down 0.01 pts
- Value
- ₹70 L
- Δ value
- up ₹0 L
- Status
- Added
What changed, Sep 2015 to Oct 2015
New New positions (0)
None.
Exited Exited (1)
- Glenmark Pharmaceuticals Limitedwas 3.8% · ₹11.9 Cr
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹13.5 Cr (+3.17% pts)
- Cipla Limitedup ₹4.6 Cr (+0.98% pts)
- Piramal Enterprises Limitedup ₹3.4 Cr (+0.97% pts)
- Syngene International Limitedup ₹3.3 Cr (+1.01% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2015, the weight rose most in Healthcare Services (+1.3 pts) and Finance (+1.0 pts), and fell most in Pharmaceuticals & Biotechnology (−2.1 pts) and Pharmaceuticals (−0.3 pts).
- Healthcare Services1.1% → 2.4%+1.3 pts
- Finance1.7% → 2.7%+1.0 pts
- Pharmaceuticals & Biotechnology91.7% → 89.6%−2.1 pts
- Pharmaceuticals5.6% → 5.2%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2014 | Apr 2015 | Jul 2015 | Sep 2015 | Oct 2015 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 84.9% | 92.3% | 92.7% | 91.7% | 89.6% |
| Pharmaceuticals | 14.0% | 6.5% | 6.3% | 5.6% | 5.2% |
| Finance | 1.1% | 1.1% | 1.0% | 1.7% | 2.7% |
| Healthcare Services | — | — | — | 1.1% | 2.4% |
Allocation in Oct 2015change vs Sep 2015
- Pharmaceuticals & Biotechnology (16)89.6%▼ 2.1 pts
- Pharmaceuticals (5)5.2%▼ 0.3 pts
- Finance (1)2.7%▲ 1.0 pts
- Healthcare Services (2)2.4%▲ 1.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Oct 2015
9.4%
▼ 1.2 pts vs Sep 2015
- Cash alone
- 9.4%
- cash and net receivables
- A year earlier
- 7.2%
- Oct 2014 · now ▲ 2.2 pts
- Last 12 months
- 5.3% – 10.7%
- lowest to highest · record 11.6% in Mar 2014
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.